Dsruptive Subdermals AB

Leaders in Implantable NFC Technology - Real Time Data Tracking.

Research & Product Development

Established

April 1, 2019

HQ Location

Stockholm, Sweden

Company

Dsruptive Subdermals AB

CEO

Oskar Moore

Visit website

+3000

Chipped Humans

Clinical Studies

Dsruptive Subdermals is building the next interface between biology and technology. Through implantable NFC-powered microdevices placed discreetly beneath the skin, the company enables continuous, frictionless physiological data capture - without reliance on external wearables.

More than 40 years experience.

From our founder

“Nordic Group invested in Dsruptive because the future of healthcare will be continuous, integrated, and data-native. Implantable health technology moves beyond episodic diagnostics toward seamless human–technology convergence - aligning with our long-term vision of proactive, precision-driven health optimisation.”

— Chris Moore

CEO Nordic Group

More companies

Our company portfolio

Functional and Genetic Health Testing

Healthcare Uniquely Tailored to the Individual

Private Clinic for Functional Medicine

Unique Supplements for Health

Monitoring Antibiotic Resistance in the Environment

Delivering the Future of Supplements

Leaders in Implantable NFC Technology - Real Time Data Tracking.

The Future of Pet Testing

Revolutionising Breast Health

The Platform for Next-Level Pet Care

NORDIC GROUP

Shaping the Future of Healthcare

Our companies

Let's connect

We provide the interconnected ecosystem driving the global shift from reactive treatment to predictive, personalized wellness. By equipping practitioners with advanced laboratory assays, genetic insights, and targeted nutraceuticals, we provide the essential tools for human longevity.